Oxygen affinity is decreased in patients with polycythaemia vera and essential thrombocythaemia (vol 64, pg 71, 2004)

被引:0
|
作者
Johansson, P
Brudin, G
Nilsson, B
Andréasson, B
机构
来源
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION | 2004年 / 64卷 / 02期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:167 / 167
页数:1
相关论文
共 40 条
  • [21] Association of red blood cell distribution width and lactate dehydrogenase with disease transformation in essential thrombocythaemia and polycythaemia vera patients: a UK cohort study using electronic health records
    Rockenschaub, Patrick
    Carpenter, Lewis
    Hatton, Grace
    D 'Abrantes, Sofia
    Sims, Edward
    Scott-Ram, Nick
    Duces, Aurelie
    Emanuel, Gabrielle
    Mead, Adam
    Drummond, Mark
    Lipunova, Nadezda
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 77 - 77
  • [22] Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial (vol 4, pg e165, 2017)
    Masarova, L.
    Patel, K. P.
    Newberry, K. J.
    LANCET HAEMATOLOGY, 2017, 4 (06): : E257 - E257
  • [23] A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF)
    Mascarenhas, John
    Lu, Min
    Li, Timmy
    Petersen, Bruce
    Hochman, Tsivia
    Najfeld, Vesna
    Goldberg, Judith D.
    Hoffman, Ronald
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (01) : 68 - 75
  • [24] Allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis or acute myeloid leukaemia secondary to a previous polycythaemia vera or essential thrombocythaemia: report from the MDS subcommittee of the Chronic Leukaemia Working Party
    Rambaldi, A.
    van Biezen, A.
    Scholten, M.
    Oldani, E.
    Carobbio, A.
    Finke, J.
    Nagler, A.
    Volin, L.
    Lamy, T.
    Arnold, R.
    Mohty, M.
    Michallet, M.
    Kroger, N.
    de Witte, T.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S361 - S361
  • [25] Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia (vol 36, pg 488, 2012)
    Francis, Sebastian
    Bareford, David
    Baggott, Christina
    Thachil, Jecko
    LEUKEMIA RESEARCH, 2012, 36 (09) : 1210 - 1210
  • [26] Impaired baroreflux gain in patients with inappropriate sinus tachycardia (vol 16, pg 64, 2004)
    Leon, H
    Guzman, JC
    Kuusela, T
    Dillenberg, R
    Kamath, M
    Morillo, CA
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (02) : 109 - 109
  • [27] Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial
    Masarova, Lucia
    Patel, Keyur P.
    Newberry, Kate J.
    Cortes, Jorge
    Borthakur, Gautam
    Konopleva, Marina
    Estrov, Zeev
    Kantarjian, Hagop
    Verstovsek, Srdan
    LANCET HAEMATOLOGY, 2017, 4 (04): : E165 - E175
  • [28] Contibutions of advective and diffusive oxygen transport through multilayer composite caps over mine waste (vol 71, pg 193, 2004)
    Kim, H
    Benson, CH
    JOURNAL OF CONTAMINANT HYDROLOGY, 2005, 78 (03) : 257 - 257
  • [29] Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials
    Mazza, Gina L.
    Mead-Harvey, Carolyn
    Mascarenhas, John
    Yacoub, Abdulraheem
    Kosiorek, Heidi E.
    Hoffman, Ronald
    Dueck, Amylou C.
    Mesa, Ruben A.
    LANCET HAEMATOLOGY, 2022, 9 (01): : E38 - E48
  • [30] Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment (vol 126, pg 389, 2004)
    Barczyk, A
    Sozanska, E
    Trzaska, M
    Pierzchala, W
    CHEST, 2005, 127 (01) : 415 - 415